For more information on our recent data notice, please click here

Menu
Search

Reduced Heart Rate Variability May Indicate Greater Vulnerability to PTSD

 

September 10, 2015  |  

​A prospective longitudinal study of U.S. Marines suggests that reduced heart rate variability – the changing time interval between heartbeats – may be a contributing risk factor for post-traumatic stress disorder (PTSD). The findings are reported in the September 9 online issue of JAMA Psychiatry by researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System.

Even at rest, the normal rhythm of the heart fluctuates, reflecting influences and changes in other parts of the body. Generally speaking, the greater the heart rate variability or HRV, the better. Conversely, reduced HRV suggests poorer functioning of regulatory systems in the body and has been cited as an indicator or predictor for a number of conditions, such as fetal distress, heart disease, depression, asthma, diabetic neuropathy and disorders of the autonomic nervous system, which controls bodily functions not consciously directed, such as heartbeat, breathing and digestion.

HRV has been associated with PTSD, a mental health condition linked to a number of maladies, including anger, insomnia, substance abuse and chronic depression. PTSD is particularly associated with persons deployed to war. For example, the lifetime prevalence in Vietnam-era combat veterans is 19 percent. For veterans of Iraq and Afghanistan, it is 13 to 15 percent. In the general U.S. population, the PTSD prevalence rate is 8 percent.

Researchers investigated whether reduced HRV before combat deployment conferred increased risk of a PTSD diagnosis after deployment. From July 2008 to October 2013, they assessed two large cohorts of active-duty Marines one to two months before combat deployment and again four to six months after their return. After accounting for deployment-related combat exposure, the researchers found that U.S. Marines with reduced HRV prior to deployment displayed increased vulnerability to PTSD upon return.

“The evidence is initial and modest,” said Arpi Minassian, PhD, clinical professor of psychiatry at UC San Diego School of Medicine and first author of the study. “It suggests that an altered state of the autonomic nervous system may contribute to vulnerability and resilience to PTSD, along with known risk factors, such as combat exposure and preexisting stress and trauma symptoms.”

The researchers said that if the findings are buttressed by future studies, it may suggest new opportunities for preventing PTSD by addressing the biology of the autonomic nervous system.

Co-authors include Adam X. Maihofer, Dewleen G. Baker, Caroline M. Nievergelt, Mark A. Geyer, and Victoria B. Risbrough, all at the Center of Excellence for Stress and Mental Health, Veterans Affairs San Diego and UC San Diego.

Funding support for this research came, in part, from Veterans Affairs Health Service Research and Development, the U.S. Marine Corps, the U.S. Navy Bureau of Medicine and Surgery, the Naval Medical Research Center’s Advanced Medical Development program, a Biomedical Laboratory Research and Development Veterans Affairs Merit award and National Institutes of Health grants MH093500, MH100351 and P30 DK079337.

Disclosure: Geyer disclosed a financial relationship for NIH Grant MH093500. He received consulting compensation from Omeros.


​Care at UC San Diego Health

Psychiatry and Behavioral Health



Media Contact

Scott LaFee
858-249-0431
slafee@health.ucsd.edu

Cynthia Butler
858-552-4373
cynthia.butler@va.gov

Share This Article


Related News

9/27/2021
Researchers describe how withdrawal from nicotine, methamphetamine and cocaine alters the functional architecture and patterns in the brains of mice, compared to control animals, a key to developing a ...
8/25/2021
Stem cell models derived from people with specific genomic variation recapitulate aspects of their autism spectrum disorder, providing a valuable model to study the condition and look for therapeutic ...
6/29/2021
Researchers expose live lobsters to vaporized cannabis and confirm the crustaceans absorb THC. Whether the psychoactive compound affects behavior remains open question.
5/19/2021
UC San Diego Health is conducting the first known randomized, double-blind, placebo-controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.



Follow Us